0
0

Department of Health and Human Services Awarded a Contract to MATRISOME BIO, INC. for $354,456.00

Signed on

9/11/2025, 12:00 AM

MATRISOME BIO, INC. Government Contract #75N91025C00039

MATRISOME BIO, INC. was awarded a contract with the United States Government for $354,456.00. The contract was awarded by the agency office NIH NCI, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is Matrisome Bio, Inc., a small U.S.-owned business located in Cambridge, Massachusetts. The contract, funded by the Department of Health and Human Services through the National Institutes of Health, is for developing theranostic radioligands targeting disease-specific components in patients with hereditary breast and ovarian cancer, with a total value of $354,456. The contract was awarded through a negotiated proposal/quote process with full and open competition.

Contract Details

Contract ID75N91025C00039
Contract TypeD
Total Obligation$354,456.00
Exercised Options$354,456.00
Base Amount + Options$354,456.00
Date Signed2025-09-11
Contract DescriptionNOVEL THERANOSTIC RADIOLIGANDS TARGETING DISEASE-SPECIFIC EXTRACELLULAR MATRIX COMPONENTS SPECIFIC TO TUMOR AND METASTATIC LESIONS IN PATIENTS SUFFERING FROM HEREDITARY BREAST AND OVARIAN CANCER (HBOC)
Start Date2025-09-15
End Date2026-09-14

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyNational Institutes of Health
Awarding OfficeNIH NCI
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyNational Institutes of Health
Funding OfficeNIH NCI

Recipient Details

RecipientMATRISOME BIO, INC.
Recipient Location700 MAIN ST CAMBRIDGE MASSACHUSETTS, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0$354,456.00September 11, 2025

National Institutes of Health, a sub agency of Department of Health and Human Services, issued a payment of $354,456.00 to MATRISOME BIO, INC.. The payment included a Subsidy Cost of $0.00.